Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib

Beuselinck, Benoit; Van Brussel, Thomas; Verbiest, Annelies; Vanmechelen, Maxime; Couchy, Gabrielle; Oudard, Stéphane; Elaidi, Reza-Thierry; Roussel, Eduard; Albersen, Maarten; Debruyne, Philip; Baldewijns, Marcella; Machiels, Jean-Pascal; Richard, Vincent; Verschaeve, Vincent; Wolter, Pascal; Rioux-Leclercq, Nathalie; Laguerre, Brigitte; Zucman-Rossi, Jessica; Lambrechts, Diether

doi:10.3233/KCA-200086

Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib

Author:

Beuselinck, Benoit

Van Brussel, Thomas ; Verbiest, Annelies ; Vanmechelen, Maxime ; Couchy, Gabrielle ; Oudard, Stéphane ; Elaidi, Reza-Thierry ; Roussel, Eduard ; Albersen, Maarten ; Debruyne, Philip ; Baldewijns, Marcella ; Machiels, Jean-Pascal ; Richard, Vincent ; Verschaeve, Vincent ; Wolter, Pascal ; Rioux-Leclercq, Nathalie ; Laguerre, Brigitte ; Zucman-Rossi, Jessica ; Lambrechts, Diether

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, Urology & Nephrology, Renal cell carcinoma, sunitinib, outcome, single nucleotide polymorphisms, 1ST-LINE SUNITINIB, INTERFERON-ALPHA, PAZOPANIB, MARKERS, ANGIOGENESIS, BIOMARKERS, SURVIVAL, EFFICACY, PROTEINS